Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

David Fisher

14 та иш

Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa

  1. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo

    Jinqian Mao, Yunfei Chen, Qiushuo Zong +10

    МақолаPhytochemistry and Bioactivity StudiesFrontiers in Immunology20240 иқтибос
    ABI

  2. Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience

    Huan Wang, Miao Luo, David Fisher +5

    МақолаHematological disorders and diagnosticsFrontiers in Microbiology20240 иқтибос
    ABI

  3. Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis

    Cuiling Liu, David Fisher, Khrystyna Pronyuk +4

    МақолаParasites and Host InteractionsFrontiers in Pharmacology20240 иқтибос
    ABI

  4. Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response

    Lin Chen, Guozhi Wu, Tao Wu +6

    МақолаFerroptosis and cancer prognosisCurrent Medical Science20240 иқтибос
    ABI

  5. The History of Controlling and Treating Infectious Diseases in Ancient China

    Cuiling Liu, Tao Zhou, Liang-bin Cheng +5

    МақолаZoonotic diseases and public healthCurrent Medical Science20240 иқтибос
    ABI

  6. Lunasin: Exploring the pharmacological potential of a soy-derived peptide

    Hao Zhang, Yiping Dang, Yuan-Jin Guo +9

    МақолаProtein Hydrolysis and Bioactive PeptidesEuropean Journal of Medicinal Chemistry20250 иқтибос
    ABI

  7. Association of platelet to albumin ratio with metabolic dysfunction-associated steatotic liver disease based on the National Health and Nutrition Survey 2017–2018

    Jinbo Xie, Qingliu He, David Fisher +3

    МақолаLiver Disease Diagnosis and TreatmentScientific Reports20250 иқтибос
    ABI

  8. IGFBP3-mediated effects of an effective combination therapy on HCC

    Lin Chen, Lei Zhao, Guozhi Wu +5

    МақолаGrowth Hormone and Insulin-like Growth FactorsScientific Reports20250 иқтибос
    ABI

  9. Antiviral treatment for viral pneumonia: current drugs and natural compounds

    Hao Zhang, Ge Chen, David Fisher +8

    Шарҳ мақолаPharmacological Effects of Natural CompoundsVirology Journal20250 иқтибос
    ABI

  10. Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems

    Chengyi He, Yunfei Chen, Jiao Xie +7

    Шарҳ мақолаMedicinal plant effects and applicationsFrontiers in Pharmacology20250 иқтибос
    ABI

  11. Current status and trend of global research on the pharmacological effects of emodin family: bibliometric study and visual analysis

    Miao Luo, Luorui Shang, Jinbo Xie +8

    Шарҳ мақолаPhytochemistry and biological activity of medicinal plantsNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  12. The effects of cynaroside on lipid metabolism and lipid-related diseases: a mechanistic overview

    Chenyi Cen, Jiahuan Li, Pu Zhou +5

    Шарҳ мақолаCynara cardunculus studiesFrontiers in Pharmacology20250 иқтибос
    ABI

  13. Protective role of sulforaphane in lipid metabolism-related diseases

    Lingfeng Zhao, Jiahuan Li, Yiping Dang +5

    Шарҳ мақолаGenomics, phytochemicals, and oxidative stressMolecular Biology Reports20250 иқтибос
    ABI

  14. Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

    Hao Zhang, Yiping Dang, Yuanjin Guo +8

    МақолаMedicinal plant effects and applicationsEuropean Journal of Pharmacology20260 иқтибос
    ABI